China grants conditional approval for Merck’s COVID treatment
Molnupiravir, developed by Merck, is approved to be used in adult patients who have mild-to-medium COVID infection and a high risk…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
National Medical Products Administration
US FDA grants Orphan Drug Designation to BCMA CAR-T cell therapy co-developed by Innovent Biologics…
ODD will accelerate drug development and registration action in the US
Kintor Pharma announces first patient dosing of phase-III clinical trial of Pyrilutamide to treat…
On 24th November, 2021, Kintor Pharma announced that China's National Medical Products Administration (NMPA) greenlighted the…
China approves clinical trials for 16 indigenous COVID-19 vaccines
China has already given conditional approval to two inactivated COVID-19 vaccines made by state-owned developers -- Sinopharm and…